BMB Reports 2024; 57(7): 311-317  https://doi.org/10.5483/BMBRep.2024-0077
Electrophysiological insights with brain organoid models: a brief review
Rian Kang1,2, Soomin Park1,3, Saewoon Shin1, Gyusoo Bak1,2 & Jong-Chan Park1,2,3,*
1Institute of Quantum Biophysics, Sungkyunkwan University, Suwon 16419, 2Department of Metabiohealth, Sungkyunkwan University, Suwon 16419, 3Department of Biophysics, Sungkyunkwan University, Suwon 16419, Korea
Correspondence to: Tel: +82-31-299-4795; Fax: +82-31-299-4093; E-mail: jongchan@g.skku.edu
Received: April 28, 2024; Revised: July 19, 2024; Accepted: June 19, 2024; Published online: July 3, 2024.
© Korean Society for Biochemistry and Molecular Biology. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Brain organoid is a three-dimensional (3D) tissue derived from stem cells such as induced pluripotent stem cells (iPSCs) embryonic stem cells (ESCs) that reflect real human brain structure. It replicates the complexity and development of the human brain, enabling studies of the human brain in vitro. With emerging technologies, its application is various, including disease modeling and drug screening. A variety of experimental methods have been used to study structural and molecular characteristics of brain organoids. However, electrophysiological analysis is necessary to understand their functional characteristics and complexity. Although electrophysiological approaches have rapidly advanced for monolayered cells, there are some limitations in studying electrophysiological and neural network characteristics due to the lack of 3D characteristics. Herein, electrophysiological measurement and analytical methods related to neural complexity and 3D characteristics of brain organoids are reviewed. Overall, electrophysiological understanding of brain organoids allows us to overcome limitations of monolayer in vitro cell culture models, providing deep insights into the neural network complex of the real human brain and new ways of disease modeling.
Keywords: Brain organoids, Brainwave, Electrophysiology, Neuronal network
INTRODUCTION

Our understanding of brain development and physiology has primarily been studied using animal models because it is difficult to have a direct access to human brain (1, 2). However, these models do not fully represent molecular features, genetic characteristics, and functional complexity of the human brain (3). Particularly, research involving embryonic brains is essential for understanding human brain development but challenging to approach. Recently, the development of organoids derived from pluripotent stem cells has enhanced our understanding of the human brain (4-6). With the establishment of protocols inducing differentiation from human induced pluripotent stem cells through embryoid body to specific regions of the brain, research within the in vitro model now permits investigation into the complexity of the human brain, encompassing various cell types (7, 8). Single-cell RNA sequencing and immunohistochemistry have facilitated the identification of cell types such as astrocytes, neurons, and oligodendrocytes, as well as the observation of diverse inhibitory and excitatory neurons (9-11). Despite advancements in understanding differentiation processes of the human brain and structural characteristics of brain organoids, functional measurement of neuronal and glial cells in organoids remains the subject of ongoing research. Brain organoids form diverse and rhythmical cellular networks, mimicking distinctive and periodic brain signals observed in humans, known as neuronal oscillations (12-14). Therefore, electrophysiological investigations of brain organoids have the potential to reveal functionally unexplored measurements owing to the challenging accessibility of the human brain.

In this review, cellular compositions of brain organoids and resulting electrophysiological characteristics were first emphasized. Next, we discussed invasive or non-invasive methods for investigating electrical properties of brain organoids. Finally, we described various applications microelectrode arrays to offer non-invasive insights into the complexity and neuronal networks of brain organoids, ranging from developmental study to organoid intelligence.

CELLULAR COMPONENT AND ELECTRICAL CHARACTERIZATIONS OF BRAIN ORGANOIDS

Recently, numerous organoid protocols representing various brain regions have been developed, with cortical organoids (COs) effectively reflecting unique electrophysiological characteristics of the human brain. Cortical organoids generated from induced pluripotent stem cells (iPSCs) can differentiate from embryonic body under the influence of fibroblast growth factor 2 (FGF2). Epidermal growth factor (EGF) can be added to promote differentiation into neural cells. Subsequently, FGF2 and EGF are replaced with brain-derived neurotrophic factor (BDNF) and neurotrophic factor 3 (NT3) to further induce differentiation into mature neurons.

Cortical organoids were found to express PAX6, a marker for neural progenitor cells, in over 85% of cells by day 18. By day 25, organoids exhibited a lumen structure composed of cells expressing N-cadherin (NCAD), resembling the ventricular-like zone (VZ). Furthermore, it was observed that the VZ-like zone was surrounded by an intermediate zone similar to the subventricular zone (SVZ). The presence of glial cells such as astrocytes and oligodendrocyte progenitor cells, characteristic of the cerebral cortex, was also noted. This suggests that cortical organoids closely mimic developmental processes and structures of the human cerebral cortex, reproducing the complexity of neurons and thereby demonstrating the ability to recapitulate various physiological and functional aspects of the human brain in vitro (7).

Physiological complexity of the brain arises from integration of various organs such as blood vessels, the spinal cord, and the peripheral nervous system (9). Consequently, research has predominantly relied on animal models. However, human specific genes which is not expressed in animal models may influence brain physiology. Particularly, studies comparing human and chimpanzee brain organoids have found that genes are specifically expressed in humans, including those abundant in human radial glia, intermediate progenitors, and neurons. These differences imply that animal models may not fully represent the human brain. However, human brain organoids have been shown to faithfully reflect genes expressed in the actual human brain (15). We emphasize the significant role of organoids in human electrophysiological research.

APPLICATIONS OF BRAIN ORGANOIDS

Research on the human brain has mainly been conducted using postmortem brain tissues and animal models. While these methods have increased our understanding of the brain, it is difficult to access developmental stages and functional characteristics of the human brain using these methods (12, 15-17). Brain organoids have garnered considerable attention due to their resemblance to the human brain and potential for various applications (18). Brain organoids hold promise for diverse applications, notably in disease modeling. They can mimic congenital brain malformations and neurodegenerative disorders, reflecting genetic characteristics of patients’ cells. As such, brain organoids offer valuable tools for drug screening and therapy development (16, 19-24).

Research on the developmental process of the human brain is also feasible. Specifically, the outer subventricular zone (OSVZ), which is significantly underrepresented in the developmental process of mice, is abundantly found in brain organoids (25, 26). This enables studies on the complexity of the human cortical structure, reflecting key features of the human brain within laboratory settings. Additionally, inter-species comparisons allow for investigations into the evolution of the human brain. In such studies, electrophysiological investigations play a crucial role in confirming functional properties of brain organoids.

METHODS FOR ELECTROPHYSIOLOGICAL INVESTIGATION OF BRAIN ORGANOIDS

Calcium imaging

Calcium ions are utilized to generate intracellular signals regulating various functions in different cell types. Particularly in neurons, calcium concentration varies depending on neurotransmitters released at nerve terminals. In a resting state, most neurons maintain an intracellular calcium concentration of approximately 50-100 nM, which transiently increases to levels 10-100 times higher during action potentials. This can also be invoked in various fundamental events. It can form more complex intercellular signals such as brainwaves. Calcium imaging enables visualization of neuronal activity by labeling calcium with fluorescent calcium indicators such as Oregon Green BAPTA and Fluo-4 dyes, followed by observation using imaging equipment such as a two-photon microscope (27).

For instance, spontaneous calcium dynamics have been detected on the 76th day using a two-photon microscope to investigate neuronal functions of cerebral organoids. Furthermore, neuronal networks isolated from organoids exhibit synchronized activity in some small cell groups on post-harvest day 16, followed by synchronized network activity on day 30. Additionally, the addition of glutamate resulted in an explosively observed synchronized response, whereas its absence in the same field led to a decrease. Conversely, the addition of bicuculline methochloride, a GABAA receptor antagonist (−), significantly increased the neuronal activity (28). Calcium imaging allows for the observation of neuronal activity and networks using spatiotemporal calcium dynamics. However, calcium imaging is limited by temporal resolution and the measurable depth of field (29).

Patch clamp

Patch-clamp techniques allow us to record electrophysiological characteristics of organoids. Unlike calcium imaging, patch-clamp allows for the recording of potentials occurring in neurons at the millisecond level (30, 31). Sivitilli et al. have employed patch clamp to assess neuronal function (32). Whole-cell patch clamping was performed to measure electrophysiological outputs in fresh slices prepared from 12- and 24-week cerebral organoids for comparing mature and developing neurons in organoids. Developing neurons exhibited fired action potential with slow kinetics and low amplitude. On the other hand, mature neurons fired action potentials with fast kinetics and high amplitude. Moreover, they generated high amplitudes and stable spontaneous action potentials.

Patch clamping provides neuronal activity and amplitude voltage data induced from organoid’s neuronal cell. However, to measure electrophysiological properties of organoids by patch clamp, it is necessary to slice organoids or isolate single neurons. Additionally, patch-clamp recordings are restricted to capturing signals from single cells in organoids, thereby lacking the ability to provide insight into neuronal networks in living organoids (32).

Microelectrode array (MEA)

Microelectrode array (MEA) is a method of collecting neuronal electrophysiological data through microelectrodes arranged on the bottom of a culture plate. When in contact with organoids, electrodes can record neuronal activity and network patterns. Electrophysiological signals collected through MEA undergo amplification and filtering processes, enabling various types of analyses. Primitive MEA data can extract relatively high-frequency data ranging from 300 to 3,000 Hz, allowing for the generation of spike raster plots. These plots enable the analysis of neuronal bursts and network activity. Additionally, analyzing the local field potential of organoids is achievable low-frequency ranging from 1 Hz to 1,000 Hz. Therefore, it is feasible to measure both the overall oscillation of brain organoids and the spike activity of individual neurons over long-term culture periods (Table 1) (33).

ORGANOID-BASED STUDY VIA MEA

Recording complicate electrophysiological properties of brain organoids is a challenging task. It is also indispensable for understanding the brain. While calcium imaging allows visualization of overall neuronal activity, it suffers from limitations such as temporal resolution, shallow penetration depth of fluorescent dyes, and an inability to observe over prolonged culture periods. Similarly, techniques such as patch clamp struggle to reflect complex neuronal networks and oscillatory patterns within organoids. Recent research has turned to the use of multi-electrode array (MEA) to investigate spontaneous neural activity and oscillations in long-term and sustained culture environments. This approach holds promise for playing a crucial role in human brain differentiation and disease modeling. The current advancement of MEA involves parallel development of devices to reflect three-dimensional characteristics of organoids and the utilization of MEA for functional measurement and analysis of various organoids (Fig. 1).

Electrophysiological changes along brain development

The difficulty in accessing developmental changes in fetal and neonatal brains has led to the substitution of animal models. However, as animal models do not fully represent human brain development, measuring neural oscillations in organoids generated from embryonic bodies can enhance our understanding of human brain development. For instance, Trujillo et al. measured characteristics of oscillations at different developmental stages of brain organoids using MEA (33). Cortical organoids exhibited high phase-amplitude coupling between oscillatory delta (1-4 Hz) and broadband gamma activity (100-400 Hz). Additionally, 10-month-old organoids showed robust spikes and increased burst frequency, a pattern not observed in spheroids composed of differentiated neurons, thus demonstrating continuously evolving neural networks in organoids. Furthermore, local field potential of organoids has been reported to closely resemble preterm neonatal EEG patterns (1).

Drug screening

MEA offers a non-invasive means to measure electrophysiological properties, making it an ideal platform for recording drug responses while culturing organoids. Yokoi et al. have induced epileptic seizures in cerebral organoids by treating them with pentylenetetrazol (PTZ) and screened effects of antiepileptic drugs (AEDs) (34). Electrophysiological signals of organoids in response to drugs were recorded via MEA and analyzed within a frequency range of < 500 Hz. After PTZ treatment, raw waveforms were recorded 10 minutes later. The total spike rate of neurons showed a concentration-dependent increase in response to PTZ. Furthermore, when analyzing waveforms between 4 and 500 Hz before and after PTZ administration, the power of frequencies at 4-10 Hz increased in the PTZ-treated group. Additionally, as the concentration of PTZ increased, the frequency power exhibited a significant increase. Furthermore, when administering perampanel, an antiepileptic drug, oscillation data obtained through MEA showed an increase in frequencies around 0-30 Hz. This demonstrates that perampanel inhibits epileptic seizures in organoids (34). This study demonstrates that brain organoids exhibit unique characteristics in frequency components below 500 Hz and that these characteristics can be altered by drugs. If responses of organoids to compounds can be identified through frequency component analysis obtained via MEA, it will be possible to predict how new drugs for brain disorders will react in the human brain.

3D MEA for brain organoid electrophysiology

To overcome limitations of planner MEA, it is essential to develop MEA that reflects the three-dimensional characteristic of organoids. For example, inspired by human EEG measurements, one study has produced MEA wrapped in the form of a shell with self-folding polymer bilayer (35). This device was designed to adjust curvature depending on the diameter of the organoid. In that study, compared to existing 2D MEA, the signal-to-noise ratio (SNR) was significantly increased. Increased electrophysiological responses to stimulation such as glutamate were also captured. In conclusion, recording three-dimensional signals rather than signals in one plane will be advantageous for electrophysiological understanding of brain organoids.

Organoids can increase in thickness from 500 μm to 4 mm, unlike 2D cell cultures (36). There is ongoing research utilizing stretchable mesh nanoelectronics to obtain stable 3D biological-electrical interfaces for developing organoids (37, 38). This technology is, softer than brain tissue, accommodates compression, folding, and expansion during organoid formation. Stretchable mesh nanoelectronics can seamlessly integrate with organoid tissues, uniformly distributing across the entire area to record electrophysiological signals. Consequently, rhythmical oscillations in spontaneous local field potentials (LFPs) were observed at one month after differentiation and from tissue-wide embedded mesh electrodes in the range of 0-1 kHz three months later.

Reflecting the 3D nature of organoids necessitates material technologies that are sensitive and flexible without compromising cell viability (39). Continued research in this direction is expected to contribute to a more comprehensive understanding of neuron networks distributed within organoids.

Organoid intelligence (OI)

Human brain consisting of 86 to 100 billion neurons with over 1,015 connections can surpass machines in processing sparse or uncertain data despite being slower than supercomputers in simple data computation (40, 41). A report has suggested that a supercomputer takes 40 minutes to model 1% of human brain activity for 1 second in complex decision-making scenarios (42). Thus, modeling the human brain has high efficiency for inference using sparse and uncertain data. Organoids mimic neuronal networks of the human brain, exhibiting high neuron density and synaptic generation crucial for learning. They can be cultured for over a year. Through electrophysiological recordings obtained via MEA, unsupervised learning via input-output patterns becomes feasible.

In the case that organoids are placed on MEA electrodes for unsupervised learning, changes in neuronal connectivity in response to different patterns of stimulations have been reported (43, 44). Additionally, nonlinear regression analysis demonstrated precise prediction results as organoids underwent learning. This demonstrates that organoids can replicate the brain’s nonlinear properties for AI machine learning and computing (43).

The Baltimore Declaration toward the exploration of organoid intelligence, established in February 2022, is gaining recognition as an emerging scientific field. Expectations lie in the electrophysiological understanding of brain organoids fostering the direction and advancement of organoid computing (44).

Other applicable bio-convergence technologies in electrophysiology

Although research utilizing organoids for electrophysiological studies offers many advantages for understanding the functionality of the human brain, significant advancements are still needed to faithfully mimic the activity of the adult brain (33, 45). To overcome these limitations, recent efforts have been actively conducted to enhance the complexity and connectivity of organoids using technologies such as bioprinting and microfluidic chips (46, 47). These studies could bridge the gap between human brains and organoids, opening possibilities to investigate electrophysiological features reminiscent of those observed in the human brain because of its complexity.

Moreover, brain waves in living organisms can vary in response to different stimuli (48, 49). Recently, there has been a growing interest in utilizing invasive/noninvasive stimuli to treat neurodegenerative diseases (47). Techniques to overcome pathological oscillations through appropriate stimulation of brain organoids are likely necessary. Optogenetics and sonogenetics, which regulate neuronal activity through light and ultrasound stimulation, respectively, have gained attention in research aiming to suppress pathological activity in the brain. Their application in organoids is being explored (50).

CONCLUDING REMARKS

In this review, we briefly introduced brain organoid’s electrophysiological features and measuring methods. Utilizing electrophysiological characteristics of organoids for functional measurements is a crucial perspective in understanding them. The process by which unique neuronal networks and waves in the human brain form is not yet fully understood. Therefore, it is necessary to develop methods that reflect three-dimensional features of organoids and the connectivity of neuronal and glial cell populations.

Recently, there has been a surge in research utilizing and developing microelectrode arrays (MEAs) as a method to investigate such topics. This approach allows for the measurement of spikes, confirming neuronal activity and LFP, which can enable the observation of neuronal networks from organoids. These recent advancements will not only contribute to our understanding of the human brain, but also provide valuable insights for drug screening and disease modeling using organoids.

ACKNOWLEDGEMENTS

This work was supported by a grant of Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (RS-2023-00266110). The graphical arts are generated by Biorender.com under Jong-Chan Park, Ph.D.

CONFLICTS OF INTEREST

The authors have no conflicting interests.

FIGURE
Fig. 1. Applications of organoids for electrophysiological studies.
TABLE

Methods for brain organoid electrophysiology

Methods Advantages Limitations Measurable depth Experimental duration References
Calcium imaging Real-time observation for cell-cell interaction
Does not provide voltage changing 800-900 μμ Few minutes- few hours Dana H, Mohar B, Sun Y et al (2016), Brini M, Cali T, Ottolini D and Carafoli E (2014)
Patch clamping
High-resolution voltage measurement in single-cell level
Difficulty in real-time observation of network events Single cell (5-10 μm) Few minutes- few hours Landry CR, Yip MC, Zhou Y et al (2023)
MEA Allows for approaching neural circuit activity by recording multiple channels
Limitation in approaching spatial resolution
Attachedsurface of organoids
Few days- few months Trujillo CA, Gao R, Negraes PD et al (2019), Yokoi R, Shibata M, Odawara A et al (2021)
Mesh electronics implant Measurable depth into the organoid interior Cell damage, Limitation of studying natural environment of cells Whole organoid (0.5-4 mm) Few days- few months Tasnim K and Liu J (2022), Li Q, Nan K, Le Floch P et al (2019)

REFERENCES
  1. Stiles J and Jernigan TL (2010) The basics of brain development. Neuropsychol Rev 20, 327-348.
    Pubmed KoreaMed CrossRef
  2. Kelava I and Lancaster MA (2016) Stem cell models of human brain development. Cell Stem Cell 18, 736-748.
    Pubmed CrossRef
  3. Zhao X and Bhattacharyya A (2018) Human models are needed for studying human neurodevelopmental disorders. Am J Hum Genet 103, 829-857.
    Pubmed KoreaMed CrossRef
  4. Bose R, Banerjee S and Dunbar GL (2021) Modeling neurological disorders in 3D organoids using human-derived pluripotent stem cells. Front Cell Dev Biol 9, 640212.
    Pubmed KoreaMed CrossRef
  5. Lee CT, Bendriem RM, Wu WW and Shen RF (2017) 3D brain organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders. J Biomed Sci 24, 59.
    Pubmed KoreaMed CrossRef
  6. Smirnova L and Hartung T (2024) The promise and potential of brain organoids. Adv Healthc Mater, e2302745.
    Pubmed CrossRef
  7. Pasca AM, Sloan SA and Clarke LE et al (2015) Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods 12, 671-678.
    Pubmed KoreaMed CrossRef
  8. Lancaster MA and Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9, 2329-2340.
    Pubmed KoreaMed CrossRef
  9. Kanton S, Boyle MJ and He Z et al (2019) Organoid single-cell genomic atlas uncovers human-specific features of brain development. Nature 574, 418-422.
    Pubmed CrossRef
  10. Gordon A, Yoon SJ and Tran SS et al (2021) Long-term maturation of human cortical organoids matches key early postnatal transitions. Nat Neurosci 24, 331-342.
    Pubmed KoreaMed CrossRef
  11. Qian X, Su Y and Adam CD et al (2020) Sliced human cortical organoids for modeling distinct cortical layer formation. Cell Stem Cell 26, 766-781.
    Pubmed KoreaMed CrossRef
  12. Egervari G, Kozlenkov A, Dracheva S and Hurd YL (2019) Molecular windows into the human brain for psychiatric disorders. Mol Psychiatry 24, 653-673.
    Pubmed KoreaMed CrossRef
  13. Samarasinghe RA, Miranda OA and Buth JE et al (2021) Identification of neural oscillations and epileptiform changes in human brain organoids. Nat Neurosci 24, 1488-1500.
    Pubmed KoreaMed CrossRef
  14. Sharf T, van der Molen T and Glasauer SMK et al (2022) Functional neuronal circuitry and oscillatory dynamics in human brain organoids. Nat Commun 13, 4403.
    Pubmed KoreaMed CrossRef
  15. Kim SH and Chang MY (2023) Application of human brain organoids-opportunities and challenges in modeling human brain development and neurodevelopmental diseases. Int J Mol Sci 24, 12528.
    Pubmed KoreaMed CrossRef
  16. Kim J, Lee S and Lee J et al (2022) Neurotoxicity of phenylalanine on human iPSC-derived cerebral organoids. Mol Genet Metab 136, 132-144.
    Pubmed CrossRef
  17. Cho YH, Ro EJ and Yoon JS et al (2020) 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/beta-catenin pathway activation. Nat Commun 11, 5321.
    Pubmed KoreaMed CrossRef
  18. Chen HI, Song H and Ming GL (2019) Applications of human brain organoids to clinical problems. Dev Dyn 248, 53-64.
    Pubmed KoreaMed CrossRef
  19. Chang Y, Kim J, Park H, Choi H and Kim J (2020) Modelling neurodegenerative diseases with 3D brain organoids. Biol Rev Camb Philos Soc 95, 1497-1509.
    Pubmed CrossRef
  20. Villa C, Combi R, Conconi D and Lavitrano M (2021) Patient-derived induced pluripotent stem cells (iPSCs) and cerebral organoids for drug screening and development in autism spectrum disorder: opportunities and challenges. Pharmaceutics 13, 2-280.
    Pubmed KoreaMed CrossRef
  21. Lee C, Willerth SM and Nygaard HB (2020) The use of patient-derived induced pluripotent stem cells for Alzheimer's disease modeling. Prog Neurobiol 192, 101804.
    Pubmed CrossRef
  22. Park JC, Jang SY and Lee D et al (2021) A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids. Nat Commun 12, 280.
    Pubmed KoreaMed CrossRef
  23. Choi H, Kim HJ and Yang J et al (2020) Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid models. Aging Cell 19, e13081.
    Pubmed KoreaMed CrossRef
  24. Park JC, Barahona-Torres N and Jang SY et al (2022) Multi- omics-based autophagy-related untypical subtypes in patients with cerebral amyloid pathology. Adv Sci (Weinh) 9, e2201212.
    Pubmed KoreaMed CrossRef
  25. Di Lullo E and Kriegstein AR (2017) The use of brain organoids to investigate neural development and disease. Nat Rev Neurosci 18, 573-584.
    Pubmed KoreaMed CrossRef
  26. Fietz SA, Kelava I and Vogt J et al (2010) OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nat Neurosci 13, 690-699.
    Pubmed CrossRef
  27. Berridge MJ, Lipp P and Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1, 11-21.
    Pubmed CrossRef
  28. Sakaguchi H, Ozaki Y and Ashida T et al (2019) Self-organized synchronous calcium transients in a cultured human neural network derived from cerebral organoids. Stem Cell Reports 13, 458-473.
    Pubmed KoreaMed CrossRef
  29. de Melo Reis RA, Freitas HR and de Mello FG (2020) Cell calcium imaging as a reliable method to study neuron-glial circuits. Front Neurosci 14, 569361.
    Pubmed KoreaMed CrossRef
  30. Landry CR, Yip MC and Zhou Y et al (2023) Electrophysiological and morphological characterization of single neurons in intact human brain organoids. J Neurosci Methods 394, 109898.
    Pubmed KoreaMed CrossRef
  31. Tasnim K and Liu J (2022) Emerging bioelectronics for brain organoid electrophysiology. J Mol Biol 434, 167165.
    Pubmed KoreaMed CrossRef
  32. Sivitilli AA, Gosio JT and Ghoshal B et al (2020) Robust production of uniform human cerebral organoids from pluripotent stem cells. Life Sci Alliance 3, 5.
    Pubmed KoreaMed CrossRef
  33. Trujillo CA, Gao R and Negraes PD et al (2019) Complex oscillatory waves emerging from cortical organoids model early human brain network development. Cell Stem Cell 25, 558-569.
    Pubmed KoreaMed CrossRef
  34. Yokoi R, Shibata M and Odawara A et al (2021) Analysis of signal components < 500 Hz in brain organoids coupled to microelectrode arrays: a reliable test-bed for preclinical seizure liability assessment of drugs and screening of antiepileptic drugs. Biochem Biophys Rep 28, 101148.
    Pubmed KoreaMed CrossRef
  35. Huang Q, Tang B and Romero JC et al (2022) Shell microelectrode arrays (MEAs) for brain organoids. Sci Adv 8, eabq5031.
    Pubmed KoreaMed CrossRef
  36. Qian X, Song H and Ming GL (2019) Brain organoids: advances, applications and challenges. Development 146, 8-dev166074.
    Pubmed KoreaMed CrossRef
  37. Le Floch P, Li Q and Lin Z et al (2022) Stretchable Mesh Nanoelectronics for 3D single-cell chronic electrophysiology from developing brain organoids. Adv Mater 34, e2106829.
    Pubmed KoreaMed CrossRef
  38. Li Q, Nan K and Le Floch P et al (2019) Cyborg organoids: implantation of nanoelectronics via organogenesis for tissue-wide electrophysiology. Nano Lett 19, 5781-5789.
    Pubmed CrossRef
  39. Soscia DA, Lam D and Tooker AC et al (2020) A flexible 3-dimensional microelectrode array for in vitro brain models. Lab Chip 20, 901-911.
    Pubmed CrossRef
  40. Maroso M (2023) A quest into the human brain. Science 382, 166-167.
    Pubmed CrossRef
  41. Zimmer C (2011) 100 trillion connections. Sci Am 304, 58-63.
    Pubmed CrossRef
  42. Herculano-Houzel S (2012) The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost. Proc Natl Acad Sci U S A 109 Suppl 1, 10661-10668.
    Pubmed KoreaMed CrossRef
  43. Cai H, Ao Z and Tian C et al (2023) Brain organoid computing for artificial intelligence. bioRxiv 28, 530502.
    Pubmed KoreaMed CrossRef
  44. Morales Pantoja IE, Smirnova L and Muotri AR et al (2023) First organoid intelligence (OI) workshop to form an OI community. Front Artif Intell 6, 1116870.
    Pubmed KoreaMed CrossRef
  45. Reardon S (2020) Can lab-grown brains become conscious?. Nature 586, 658-661.
    Pubmed CrossRef
  46. Saglam-Metiner P, Yildirim E, Dincer C, Basak O and Yesil-Celiktas O (2024) Humanized brain organoids-on-chip integrated with sensors for screening neuronal activity and neurotoxicity. Mikrochim Acta 191, 71.
    Pubmed CrossRef
  47. Castiglione H, Vigneron PA, Baquerre C, Yates F, Rontard J and Honegger T (2022) Human brain organoids-on-chip: advances, challenges, and perspectives for preclinical applications. Pharmaceutics 14, 11-2301.
    Pubmed KoreaMed CrossRef
  48. Khadir A, Maghareh M, Sasani Ghamsari S and Beigzadeh B (2023) Brain activity characteristics of RGB stimulus: an EEG study. Sci Rep 13, 18988.
    Pubmed KoreaMed CrossRef
  49. Qiu W, Bouakaz A, Konofagou EE and Zheng H (2021) Ultrasound for the brain: a review of physical and engineering principles, and clinical applications. IEEE Trans Ultrason Ferroelectr Freq Control 68, 6-20.
    Pubmed CrossRef
  50. Xian QX, Qiu ZH and Murugappan S et al (2023) Modulation of deep neural circuits with sonogenetics. Proceedings of the NAS 120, 22-e2220575120.
    Pubmed KoreaMed CrossRef


This Article


Cited By Articles

Funding Information

Collections

Services
Social Network Service

e-submission

Archives